Growing community of inventors

London, United Kingdom

Peter Ravn

Average Co-Inventor Count = 6.40

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 27

Peter RavnSteffen Goletz (3 patents)Peter RavnAntje Danielczyk (3 patents)Peter RavnUwe Karsten (3 patents)Peter RavnRenate Stahn (3 patents)Peter RavnPeter Astrup Christensen (3 patents)Peter RavnAndrew Grier Buchanan (1 patent)Peter RavnDavid Fairman (1 patent)Peter RavnMatthieu Chodorge (1 patent)Peter RavnJonathan Seaman (1 patent)Peter RavnAnthony Celeste (1 patent)Peter RavnPeter Astrup Christensen (1 patent)Peter RavnCristina Rondinone (1 patent)Peter RavnJoseph Grimsby (1 patent)Peter RavnPeter Ravn (4 patents)Steffen GoletzSteffen Goletz (25 patents)Antje DanielczykAntje Danielczyk (15 patents)Uwe KarstenUwe Karsten (9 patents)Renate StahnRenate Stahn (8 patents)Peter Astrup ChristensenPeter Astrup Christensen (3 patents)Andrew Grier BuchananAndrew Grier Buchanan (14 patents)David FairmanDavid Fairman (9 patents)Matthieu ChodorgeMatthieu Chodorge (7 patents)Jonathan SeamanJonathan Seaman (4 patents)Anthony CelesteAnthony Celeste (1 patent)Peter Astrup ChristensenPeter Astrup Christensen (1 patent)Cristina RondinoneCristina Rondinone (1 patent)Joseph GrimsbyJoseph Grimsby (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Medimmune Limited (2 from 541 patents)

2. Glycotope Gmbh (1 from 26 patents)

3. Glycotype Gmbh (1 from 2 patents)

4. Nemod Biotherapeutics Gmbh & Co. Kg (1 from 1 patent)


4 patents:

1. 10077319 - Anti-PCSK9-GLP-1 fusions and methods for use

2. 9345794 - Tumor-specific recognition molecules

3. 8617846 - Tumor-specific recognition molecules

4. 8088357 - Tumor-specific recognition molecules

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…